Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer

Chemotherapeutic agents, endocrine therapy and radiotherapy used in the management of breast cancer are known to cause decreased bone mineral density, and thus, increased incidence of fractures. A majority (~60%) of the breast cancer patients in India are either estrogen (ER) or progesterone hormone...

Descripción completa

Detalles Bibliográficos
Autor principal: Dhabhar, Boman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292456/
https://www.ncbi.nlm.nih.gov/pubmed/35860287
http://dx.doi.org/10.2147/BCTT.S353332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292456/
https://www.ncbi.nlm.nih.gov/pubmed/35860287
http://dx.doi.org/10.2147/BCTT.S353332

Ejemplares similares